| Notice Concerning Differences Between the Projections and Actual Results for the Consolidated First Half and Revisions to the Full-Year Consolidated Results Projections (Release from 10th, November, 2023) |
 (93KB) |
| Notice of Revisions to Previous Securities Reports (Release from 20th, October, 2023) |
(86KB) |
| Notice Regarding Establishment of a Subsidiary Company (Release from 11th, November, 2022) |
(145KB) |
| medium-term management plan "master_plan_2022" (Release from 17th, May, 2022) |
(3.71MB) |
| Notification of Commencement of Mass Production of Microfluidic Devices for Medical Use (Release from 6th, December, 2021) |
(161KB) |
| 2024/03 Term Summary of Financial Statements for the Second Quarter Ended September 30, 2023 | (587KB) |
| 2023/03 Term Summary of Financial Statements for the Fiscal Year Ended March 31, 2023 | (719KB) |
| 2023/03 Term Summary of Financial Statements for the Second Quarter Ended September 30, 2022 | (594KB) |
| 2022/03 Term Summary of Financial Statements for the Fiscal Year Ended March 31, 2022 | (492KB) |
| Interim Financial Statements Briefing Session for 2024/03 Term (Release from 14th, November, 2023) |
(3.24MB) |
| Corrections to previous financial statements briefing materials (Release from 20th, October, 2023) |
(347KB) |
| Financial Statements Briefing Session for 2023/03 Term (Release from 16th, May, 2023) |
(2.91MB) |
| Interim Financial Statements Briefing Session for 2023/03 Term (Release from 15th, November, 2022) |
(3.69MB) |
| Financial Statements Briefing Session for 2022/03 Term
(Release from 17th, May, 2022) |
(4.51MB) |
